An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)
Conditions
- Treatment of Venous Thromboembolism in Cancer Patients
- Venous Thromboembolism
- Cancer
Interventions
- DRUG: Rivaroxaban (Xarelto, BAY59-7939)
- DRUG: Apixaban
Sponsor
Bayer
Collaborators